Compare TECH & CTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TECH | CTRE |
|---|---|---|
| Founded | 1976 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.2B | 9.0B |
| IPO Year | 1995 | 2013 |
| Metric | TECH | CTRE |
|---|---|---|
| Price | $51.96 | $36.79 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 9 |
| Target Price | ★ $73.09 | $42.44 |
| AVG Volume (30 Days) | ★ 2.1M | 2.0M |
| Earning Date | 05-06-2026 | 04-30-2026 |
| Dividend Yield | 0.63% | ★ 3.61% |
| EPS Growth | N/A | ★ 96.25 |
| EPS | 0.49 | ★ 1.57 |
| Revenue | ★ $1,219,635,000.00 | $476,393,000.00 |
| Revenue This Year | $2.49 | $5.47 |
| Revenue Next Year | $6.40 | $11.16 |
| P/E Ratio | $103.96 | ★ $23.70 |
| Revenue Growth | 5.23 | ★ 60.79 |
| 52 Week Low | $46.02 | $25.82 |
| 52 Week High | $72.16 | $41.72 |
| Indicator | TECH | CTRE |
|---|---|---|
| Relative Strength Index (RSI) | 41.69 | 33.29 |
| Support Level | $49.30 | $36.60 |
| Resistance Level | $54.08 | $37.91 |
| Average True Range (ATR) | 2.14 | 1.03 |
| MACD | 0.39 | -0.35 |
| Stochastic Oscillator | 64.88 | 2.51 |
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
CareTrust REIT Inc is a self-administered, publicly traded REIT engaged in the ownership, acquisition, financing, development, and leasing of skilled nursing, seniors housing, and other healthcare-related properties. The company has one reportable segment consisting of investments in healthcare-related real estate assets. It generates revenues by leasing healthcare-related properties to healthcare operators under triple-net lease arrangements, in which the tenant is solely responsible for property-related costs. The company operates in Domestic and Foreign markets, with the majority of revenue coming from Domestic operations.